Apollo Hospitals Enterprise Ltd (APOLLOHOSP)
π― Key Takeaways
- Revenue grew 6.6% QoQ to βΉ7,044 in Q1FY27.
- Market Cap
- βΉ1.25 L Cr
- P/E Ratio
- 59.9
- P/B Ratio
- 13.20
- ROE
- 22.0%
- ROCE
- 22.1%
- Debt/Equity
- 0.60
- Div Yield
- 0.23%
- Promoter
- 28.0%
π Quarterly Results (βΉ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 |
| Operating Profit | 637 | 723 | 746 | 787 | 857 |
| OPM % | 10.9% | 11.5% | 11.5% | 11.9% | 12.2% |
| Net Profit | 441 | 494 | 516 | 551 | 610 |
| EPS | βΉ30.10 | βΉ33.19 | βΉ34.94 | βΉ36.82 | βΉ40.39 |
π¦ Balance Sheet (βΉ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 |
| Reserves | 8,140 | 7,429 | 9,408 | 9,021 |
| Borrowings | 7,864 | 7,371 | 5,659 | 7,987 |
| Total Liabilities | 20,657 | 19,548 | 22,197 | 21,950 |
| Fixed Assets | 9,819 | 9,046 | 12,310 | 9,967 |
| Investments | 2,487 | 1,012 | 2,181 | 3,008 |
| Total Assets | 20,657 | 19,548 | 22,197 | 21,950 |
π° Cash Flow Statement (βΉ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +2,856 |
| Investing | -2,148 |
| Financing | -478 |
| Net Cash Flow | +230 |
π₯ Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 28.0% | 28.0% | 28.0% | 28.0% |
| FII | 44.2% | 43.5% | 42.6% | 41.5% |
| DII | 21.1% | 21.5% | 22.8% | 23.7% |
| Public | 4.4% | 4.7% | 4.4% | 4.5% |
| # Shareholders | 1,60,556 | 1,78,648 | 1,74,610 | 1,74,281 |
βοΈ Peer Comparison β Healthcare
| Company | MCap (βΉ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.25 L Cr | 59.9 | 22.1% | β | 0.60 |
| MANIPALHOS | 98,509 | β | β | β | 1.25 |
| MAXHEALTH | 95,762 | 65.6 | 14.4% | β | 0.27 |
| ASTERDM | 64,094 | 119.0 | 12.9% | β | 0.17 |
| FORTIS | 61,831 | 59.0 | 13.3% | β | 0.29 |
| MEDANTA | 38,059 | 68.4 | 21.9% | β | 0.10 |
| NH | 36,850 | 44.9 | 13.7% | β | 1.07 |
| LALPATHLAB | 32,792 | 47.2 | 29.6% | β | 0.00 |
| KIMS | 32,345 | 151.0 | 9.7% | β | 1.44 |
| POLYMED | 16,633 | 52.8 | 15.1% | β | 0.06 |
π Peer Stock Analyses
π Recent Filings
- Announcement2026-09-25Apollo Hospitals announced that its trading window will close on October 1, 2026, for 48 hours following the release of unaudited financial results foβ¦
- Announcement2026-09-03Apollo Hospitals Enterprise Ltd announced on September 3, 2026, that shares unclaimed for seven years will be transferred to the Investor Education anβ¦
- π΄ annual report2026-08-28Apollo Hospitals Enterprise Ltd's FY 2025-26 Annual Report details its integrated healthcare ecosystem, financial performance, and strategic growth inβ¦
- π΄ Financial Results2026-08-19Apollo Hospitals announced that the transcript of its August 13, 2026 presentation on unaudited financial results for the quarter ended June 30, 2026 β¦
- π΄ Financial Results2026-08-13Apollo Hospitals announced that the audio recording of its analyst call discussing financial results for the quarter ended June 30, 2026 is now availaβ¦
- π΄ Financial Results2026-08-12Apollo Hospitals Enterprise Limited reported consolidated revenue of Rs 7,043 Crore for Q1 FY27, up 21% YoY, with PAT at Rs 581 Crore and EBITDA at Rsβ¦
- π΄ Financial Results2026-08-12Apollo Hospitals reported Q1 FY27 revenue of **βΉ70,435 million**, up 20% YoY, with net profit growing 3% and EBITDA margin at 8.2%. The company commisβ¦
- π΄ Financial Results2026-08-12Apollo Hospitals reported consolidated revenue of βΉ70,435 million for Q1 FY27, up 21% year-on-year, with PAT rising 34% to βΉ5,805 million. EBITDA reacβ¦
- π΄ Financial Results2026-08-12Apollo Hospitals Enterprise Limited reported consolidated revenue of Rs 7,043 Crore for Q1 FY27, up 21% YoY, with PAT at Rs 581 Crore and EBITDA at Rsβ¦
- π‘ Board Meeting2026-08-12The Board approved Q1 FY26 unaudited financial results showing profit after tax of [amount not verified], approved Price Waterhouse as new auditor forβ¦
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights β sign up free to unlock.
Sign Up Free β Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only β not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
π‘ Get AI alerts when APOLLOHOSP files new disclosures
Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track APOLLOHOSP β FreeFree account Β· 2 AI queries/day